Capital accelerates commercialization of WashU discoveries into life-changing diagnostics, therapeutics and medical devices
WashU startups attract record-setting $1.7 billion in private-sector investment over past year (Links to an external site)
Our surgeons and researchers are frequently featured in the media, both locally and nationally. Here are stories from around the web, featuring our expert faculty.
Capital accelerates commercialization of WashU discoveries into life-changing diagnostics, therapeutics and medical devices
16-story tower at Barnes-Jewish Hospital increases access to life-saving care and state-of-the-art imaging across the region
Adetunji T. Toriola, MD, PhD, brings a public health science approach to one of medicine’s most pressing challenges: breast cancer.
Prognosia’s AI-based imaging tech could improve prevention, early detection of breast cancer
Smoking cessation program developed by WashU Medicine researchers at Siteman Cancer Center is more effective at prolonging life than some chemotherapies.
Renowned surgical oncologist and former chair of surgery elected President-Elect of the ACS.
Young patient thriving after heart transplant
The newly completed Plaza West Tower at Barnes-Jewish Hospital will expand critical care capabilities and provide advanced imaging and the latest in surgical preparation and recovery.
Surgeon and researcher specializes in aortic disease, will be first director of new division
WashU Medicine’s Adetunji Toriola explains some of the factors driving the increase in women’s breast cancer diagnoses among women under 50.
As a grant specialist II, Danielle navigates the complex, ever-changing landscape of research funding.
A new study from Washington University School of Medicine in St. Louis describes an innovative method of analyzing mammograms that significantly improves the accuracy of predicting the risk of breast cancer development over the following five years. Using up to three years of previous mammograms, the new method identified individuals at high risk of developing breast cancer 2.3 times more accurately than the standard method, which is based on questionnaires assessing clinical risk factors alone, such as age, race and family history of breast cancer.
A small clinical trial shows promising results for patients with triple-negative breast cancer who received an investigational vaccine designed to prevent recurrence of tumors. Conducted at Washington University School of Medicine in St. Louis with a therapy designed by WashU Medicine researchers, the trial is the first to report results for this type of vaccine — known as a neoantigen DNA vaccine — for breast cancer patients.
Nerve transfer surgery is a newer procedure that can improve movement in the elbows, wrists and hands after a cervical spinal cord injury.
9-story Siteman Cancer Center building designed for patient comfort, convenience.
Riley needed multiple surgeries, including a successful operation from Kamlesh Patel, MD. Now she’s shadowing jaw surgeries during summer break.
Vascular surgeon to advance innovative patient care, research
Early outcomes look favorable, but observers say a randomized trial against redo surgery is warranted.
Vascular surgeon Mohamed Zayed, MD, PhD, MBA, received a WashU Gap Fund Award to perform translational researcḥ on technology that emerged in the CardioVascular Research Innovation in Surgery and Engineering (CVISE) Center.
Plastic surgeons are finding a lot of unwelcome surprises under the skin. Facelifts were up 18% in 2022.
Bettina Drake, professor of surgery in public health sciences at the School of Medicine, will be the inaugural faculty director of the St. Louis Confluence Collaborative for Community-Engaged Research, Teaching and Practice
Diane Newman interviews Siobhan Sutcliffe about her research on the Preventive Lower Urinary Tract Symptoms (PLUS) Consortium
Researchers from the Department of Surgery at Washington University School of Medicine looked for clues about why some types of cancer are on the rise in younger adults. They’ve found an interesting lead: a connection to accelerated biological aging.
School of Medicine leads international team funded by Cancer Grand Challenges
Graham Colditz and colorectal surgeon Will Chapman Jr. share important information about young adult colorectal cancer.
Tumor-infiltrating lymphocyte therapy has received approval from FDA for some patients with metastatic melanoma.
David DeNardo, PhD, alongside his research team in the Tumor Immunology Program at Washington University School of Medicine, is working to understand why responses to cancer immunotherapy vary among patients.
Surgical oncologist Trang Nguyen, MD, joined KMOV to discuss the type of cancer that led to country superstar Toby Keith’s death.
Last year across the country, just 658 out of 10,660 — 6% — of liver transplants came from living donors, federal data shows. But the number of living liver donors has been growing steadily over the past 10 years as the safety of donation improves and the waiting list for transplants grows.
Analyzing rates by age, race, tumor characteristics could inform prevention strategies
A research team, including Ryan Fields, MD, has received $1.5 million from the Rising Tide Foundation for Cancer Research and the Melanoma Research Alliance, for a immunotherapy trial for melanoma.
Research projects will benefit from $1.5 million in new grants announced by Siteman Cancer Center.
Scientists at Washington University School of Medicine in St. Louis have analyzed the epigenomes of tumor cells across 11 cancer types and revealed important roles for this regulatory system of the genome in the way cancer forms, grows and spreads.
Researchers at Washington University School of Medicine in St. Louis have received an NCI grant that will provide about $10.9 million to research programs for the development of new therapies for pancreatic ductal adenocarcinoma, the deadliest form of pancreatic cancer.
Prostate cancer was a wake-up call for Greg Patterson. Now he is working to encourage men to get checked—today. A morning argument may have saved Greg Patterson’s life. After pushing some health concerns aside for months, Greg finally took action after being scolded by his wife. The result was a diagnosis of stage 3 prostate cancer at age 55. Now Greg is on a mission to change the narrative about the disease.
Most people visit an average of seven different doctors and face years of misdiagnoses before discovering they have thoracic outlet syndrome. Shana Baldwin lived that painful experience until finding Robert Thompson, MD, a nationally recognized Washington University vascular surgeon at Barnes-Jewish Hospital. She is now dedicated to helping others find answers sooner.
One family’s visionary generosity to create the John M. Shoenberg Chair in Cardiovascular Disease nearly 40 years ago launched the evolution of one of the top-rated heart programs in the country
Research collaboration details molecular knowledge, step toward personalized medicine
Groundbreaking surgery performed at Barnes-Jewish Hospital in St. Louis
How Parkland Health Center and Barnes-Jewish Hospital Helped Save Him
Surgeon-scientist also to be surgeon-in-chief at St. Louis Children’s Hospital
Findings, in mice, suggest potential treatment strategy